Ameta-analysis of high-dose versus low-dose 4-factor prothrombin complex concentrate for reversal of factor Xa inhibitor-associated intracerebral hemorrhage

被引：0
|
作者：
Coleman, C. [1 ]
Karadenes, A. [1 ]
Cassano, C. [1 ]
Baker, W. L. [1 ]
机构：
[1] Univ Connecticut, Storrs, CT USA
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Use and outcomes of prothrombin complex concentrate for factor Xa inhibitor-associated bleeding
    Frank, Annabel K.
    Ganesan, Previn
    Thompson, Ashley
    Fang, Margaret C.
    THROMBOSIS RESEARCH, 2021, 198 : 132 - 134
  • [32] Evaluation of fixed dose 4-factor prothrombin complex concentrate administration for urgent warfarin reversal in patients with intracranial hemorrhage
    Scott, Rachael
    Nadler, Megan
    Kersten, Brian
    PHARMACOTHERAPY, 2016, 36 (12): : E230 - E230
  • [33] Evaluation of a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal
    McMahon, Clare
    Halfpap, Joe
    Zhao, Qianqian
    Bienvenida, Ana
    Rose, Anne E.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (10) : 1230 - 1235
  • [34] Andexanet Alfa versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa (FXa) Inhibitor-Associated Intracranial Hemorrhage: A Systematic Review of Retrospective Studies
    Ferreira, Luan Oliveira
    Oldemburg, Ricardo Andres Leon
    Leitao Filho, Joao Monteiro
    Cerveira, Rodrigo Arcoverde
    Vasconcelos, Victoria Winkler
    da Costa, Giovana Escribano
    Rodrigues, Roseny dos Reis
    Lopes, Dielly Catrina Favacho
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [35] FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN FACTOR XA INHIBITOR-ASSOCIATED INTRACRANIAL BLEEDING
    Korobey, Matthew
    Sadaka, Farid
    Javed, Muhammad Ali
    Moynihan, Meghin
    Alsaei, Ahmed
    CRITICAL CARE MEDICINE, 2020, 48
  • [36] Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa
    Barton, Cassie A.
    Hom, Marissa
    Johnson, Nathan B.
    Case, Jon
    Ran, Ran
    Schreiber, Martin
    AMERICAN JOURNAL OF SURGERY, 2018, 215 (05): : 775 - 779
  • [37] PROTHROMBIN COMPLEX CONCENTRATE PLUS LOW-DOSE FACTOR VIIA FOR BLEEDING AND REVERSAL OF COAGULOPATHY
    Baje, Mark
    Albicker, Paul
    Gayatinea, Regina
    Minh-Ha Tran
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [38] High Versus Low Fixed Dose Four Factor-Prothrombin Complex Concentrate for Warfarin Reversal in Patients with Intracranial Hemorrhage
    Compton, Frances
    Hall, Jeremy
    De Simone, Nicole
    Usmani, Amena
    Sarode, Ravi
    Burner, James Dean
    TRANSFUSION, 2021, 61 : 113A - 113A
  • [39] Reversal of Warfarin-Associated Life-Threatening Bleed With an Attenuated Dose of 4-Factor Prothrombin Complex Concentrate
    Wexler, Allyson H.
    Rech, Megan A.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (02) : 212 - 213
  • [40] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Jing Tao
    Elena N. Bukanova
    Shamsuddin Akhtar
    Journal of Intensive Care, 6
12345